Variation Seen in Cancer-Specific Mortality Rates Across Countries
THURSDAY, May 18, 2023 (HealthDay News) — Recent mortality rates decreased for major cancers in most of 47 studied countries, apart from lung cancer in women and liver cancer in men, according to a study published online May 9 in Cancer Epidemiology,…
Learn MoreUn balón gástrico tragable ayuda a las personas a perder peso
MIÉRCOLES, 17 de mayo de 2023 (HealthDay News) — Combinar un balón gástrico tragable con un medicamento para perder peso podría ser una forma de perder un peso corporal significativo, sugiere un estudio reciente. En unos ocho meses de tratamiento com…
Learn MoreEl trabajo en turnos podría hacer más daño a la salud de los hombres que a la de las mujeres
MIÉRCOLES, 17 de mayo de 2023 (HealthDay News) — Trabajar de noche puede ser duro para el cuerpo, y un nuevo estudio sugiere que quizá sea particularmente oneroso para la salud de los hombres. La investigación, enfocada en ratones de laboratorio y en…
Learn MoreFat Growing Around Muscles Could Be a Silent Killer
THURSDAY, May 18, 2023 (HealthDay News) — It’s well known that it’s unhealthy to have belly fat accumulating around your abdominal organs, but there’s a more insidious form of fat that could be even more hazardous to your health, a new study says.Fat…
Learn MoreHeart Transplant Survival Affected With COVID-19-Positive Donor Organs
THURSDAY, May 18, 2023 (HealthDay News) — Heart transplant (HT) recipients from donors with active COVID-19 have increased mortality at six months and one year, while survival is similar for recently resolved COVID-19 donors and non-COVID-19 donors, …
Learn MoreFemoral Neck BMD Lower in Men With Combat-Related Traumatic Injury
THURSDAY, May 18, 2023 (HealthDay News) — Individuals with combat-related traumatic injury (CRTI) have lower femoral neck bone mineral density (BMD), with this reduction significant only at the femoral neck of the amputated limb of amputees, accordin…
Learn MoreBrepocitinib Beneficial for Moderate-to-Severe Psoriatic Arthritis
THURSDAY, May 18, 2023 (HealthDay News) — For patients with moderately to severely active psoriatic arthritis, the tyrosine kinase 2/Janus kinase 1 inhibitor brepocitinib is effective for reducing symptoms, according to a study published online May 1…
Learn MorePeresolimab Found to Be Efficacious for Rheumatoid Arthritis
THURSDAY, May 18, 2023 (HealthDay News) — Peresolimab, a humanized immunoglobulin G1 monoclonal antibody designed to stimulate the endogenous programmed cell death protein 1 (PD-1) inhibitory pathway, is efficacious for patients with rheumatoid arthr…
Learn MoreMedicare Spending Would Increase $2.0 to $5.1 Billion With Lecanemab
THURSDAY, May 18, 2023 (HealthDay News) — If eligible patients received lecanemab, Medicare would spend an extra $2.0 to $5.1 billion annually, according to a research letter published online May 11 in JAMA Internal Medicine to coincide with the annu…
Learn MoreGlobal Burden of Chronic Respiratory Diseases Quantified
THURSDAY, May 18, 2023 (HealthDay News) — Chronic respiratory diseases (CRDs) were the third leading cause of death globally, accounting for 4.0 million deaths in 2019, according to a study published online April 25 in eClinicalMedicine.Sara Momtazma…
Learn More